Fluid resuscitation in the early management of acute pancreatitis - evidence from a systematic review and meta-analysis

HPB (Oxford). 2023 Dec;25(12):1451-1465. doi: 10.1016/j.hpb.2023.08.013. Epub 2023 Aug 29.

Abstract

Background: Third space fluid loss is one of the hallmarks of the pathophysiology of acute pancreatitis (AP) contributing to complications, including organ failure and death. We conducted a systematic review of literature to determine the ideal fluid resuscitation in the early management of AP, primarily comparing aggressive versus moderate intravenous fluid resuscitation (AIR vs MIR).

Methods: A systematic review of major reference databases was undertaken. Meta-analysis was performed using random-effects model. Bias was assessed using Cochrane risk of bias and ROBINS-I tools for randomized and non-randomised studies, respectively.

Results: Twenty studies were included in the analysis. Though there was no significant difference in mortality between AIR and MIR groups (8.3% versus 6.0%; p = 0.3), AIR cohort had significantly higher rates of organ failure (p = 0.009), including pulmonary (p = 0.02) and renal (p = 0.01) complications. Similarly, there was no difference in mortality between normal saline (NS) and Ringer's lactate (RL) (3.17% versus 3.01%; p = 0.23), though patients treated with NS had a significantly longer length of hospital stay (LOS) (p = 0.009).

Conclusions: Current evidence appears to support moderate intravenous resuscitation (level of evidence, low) with RL (level of evidence, moderate) in the early management of AP.

Publication types

  • Meta-Analysis
  • Systematic Review
  • Review

MeSH terms

  • Acute Disease
  • Fluid Therapy / adverse effects
  • Humans
  • Isotonic Solutions / adverse effects
  • Pancreatitis* / diagnosis
  • Pancreatitis* / etiology
  • Pancreatitis* / therapy
  • Ringer's Lactate

Substances

  • Isotonic Solutions
  • Ringer's Lactate